Combination therapy for the treatment of depression and other non-infectious diseases
AssigneeEaglePharma Pty Ltd
InventorPaul Turner
Life of this patent
Estimating the term…
Abstract
The invention relates to methods, uses and compositions for treating non-infectious diseases with a therapeutically effective amount of a pharmaceutical composition comprising methylsulfonylmethane, glucosamine, L-glycine, and vitamin B12 (or a derivative of any one thereof).
Claims39
A method for treating a non-infectious disease in a subject in need thereof, said method including the step of administering to the subject a therapeutically effective amount of a pharmaceutical composition comprising:
- (a) methylsulfonylmethane or a derivative thereof;
- (b) glucosamine or a derivative thereof;
- (c) L-glycine or a derivative thereof;
- and
- (d) vitamin B12 or a derivative thereof.
A method for treating stress in a subject in need thereof, said method including the step of administering to the subject a therapeutically effective amount of a pharmaceutical composition comprising:
- (a) methylsulfonylmethane or a derivative thereof;
- (b) glucosamine or a derivative thereof;
- (c) L-glycine or a derivative thereof;
- and
- (d) vitamin B12 or a derivative thereof.
A method for improving cognitive performance in a subject, said method including the step of administering to the subject a therapeutically effective amount of a pharmaceutical composition comprising:
- (a) methylsulfonylmethane or a derivative thereof;
- (b) glucosamine or a derivative thereof;
- (c) L-glycine or a derivative thereof;
- and
- (d) vitamin B or a derivative thereof.
Use A method for treating a non-infectious disease in a subject in need thereof, said method including the step of administering to the subject a therapeutically effective amount of methylsulfonylmethane or a derivative thereof, glucosamine or a derivative thereof, L-glycine or a derivative thereof, and vitamin B12 or a derivative thereof.
A pharmaceutical composition for treating a non-infectious disease, comprising methylsulfonylmethane or a derivative thereof, glucosamine or a derivative thereof, L-glycine or a derivative thereof, vitamin B12 or a derivative thereof, and a pharmaceutically acceptable carrier, diluent or excipient.
A pharmaceutical composition for improving cognitive performance, comprising methylsulfonylmethane or a derivative thereof, glucosamine or a derivative thereof, L-glycine or a derivative thereof, vitamin B12 or a derivative thereof, and a pharmaceutically acceptable carrier, diluent or excipient.
Dependencies are inferred from the claim text.